COVID-19 Vaccination in Pregnancy: Efficacy of Second-Generation Vaccines, Maternal-Neonatal Safety, and Strategies to Address Vaccine Hesitancy - Scorecard - MDSpire
Advertisement
COVID-19 Vaccination in Pregnancy: Efficacy of Second-Generation Vaccines, Maternal-Neonatal Safety, and Strategies to Address Vaccine Hesitancy
Clinical Scorecard: Vaccination Against COVID-19 During Pregnancy: Effectiveness of Newer Vaccines, Safety for Mothers and Infants, and Approaches to Mitigate Vaccine Hesitancy
At a Glance
Category
Detail
Condition
COVID-19 during pregnancy
Key Mechanisms
Physiological immune modulation increases susceptibility to severe disease; heightened oxygen consumption and reduced respiratory reserve worsen clinical outcomes.
Target Population
Pregnant women
Care Setting
Public health and maternal care
Key Highlights
Pregnant women are at increased risk for severe COVID-19 outcomes.
Elevated rates of ICU admission and maternal mortality are observed in infected pregnant women.
Vaccine hesitancy is prevalent due to concerns about adverse effects and fetal safety.
Robust evidence supports the efficacy and safety of COVID-19 vaccines.
Further research is needed to refine vaccination protocols and support equitable access.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Increased susceptibility to severe disease following SARS-CoV-2 infection.
Compromised respiratory function due to pregnancy-related physiological changes.
Patient & Prescribing Data
Pregnant women
Second-generation COVID-19 vaccines are emphasized for maternal and neonatal health outcomes.
Clinical Best Practices
Address vaccine hesitancy through education on safety and efficacy.
Ensure equitable access to vaccination for pregnant women.
Monitor maternal and neonatal health outcomes post-vaccination.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
